Login / Signup

Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo.

Rongrong LiXuhang ShenZhengyuan LiJi-Long ShenHao TangHuaming XuJilu ShenYuanhong Xu
Published in: Infection and drug resistance (2023)
The present study showed that the combination of AS101 and mefloquine yielded a notable synergistic bacteriostatic effect both in vitro and in vivo, suggesting a potential clinical application of this combination in the treatment of CRPA.
Keyphrases
  • pseudomonas aeruginosa
  • cancer therapy
  • biofilm formation
  • multidrug resistant
  • human health
  • replacement therapy